Evidence map›Paper›PMID 33965068›Full record

ArticleLancet (London, England)2021

What is the right level of spending needed for health and care in the UK?

Anita Charlesworth, Michael Anderson, Cam Donaldson, Paul Johnson, Martin Knapp, Alistair McGuire, Martin McKee, Elias Mossialos, Peter Smith, Andrew Street and 1 more

Abstract read
In one paragraph

Article in Lancet (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. CICing the partnership model into the future: a new social enterprise model for general practice?The British journal of general practice : the journal of the Royal College of General Practitioners · 2025
    Article
  4. Hidden costs of surgical complications: a retrospective cohort study.BMJ surgery, interventions, & health technologies · 2025
    Article
  5. Primary care stability as a social determinant.Frontiers in health services · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Economic Evaluations of Speech and Language Therapy Interventions: A Scoping Review.International journal of language & communication disorders
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anita CharlesworthThe Health Foundation, London, UK; College of Social Sciences, Health Services Management Centre, University of Birmingham, Birmingham, UK.
Michael AndersonDepartment of Health Policy, London School of Economics and Political Science, London, UK. Electronic address: m.anderson5@lse.ac.uk.
Cam DonaldsonYunus Centre for Social Business and Health, Glasgow Caledonian University, Glasgow, UK.
Paul JohnsonInstitute for Fiscal Studies, London, UK.
Martin KnappDepartment of Health Policy, London School of Economics and Political Science, London, UK.
Alistair McGuireDepartment of Health Policy, London School of Economics and Political Science, London, UK.
Martin McKeeDepartment of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.
Elias MossialosDepartment of Health Policy, London School of Economics and Political Science, London, UK.
Peter SmithCentre for Health Economics and Policy Innovation, Imperial College London, London, UK; Centre for Health Economics, University of York, York, UK.
Andrew StreetDepartment of Health Policy, London School of Economics and Political Science, London, UK.
Michael WoodsDepartment of Health Policy, London School of Economics and Political Science, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The health and care sector plays a valuable role in improving population health and societal wellbeing, protecting people from the financial consequences of illness, reducing health and income inequalities, and supporting economic growth. However, there is much debate regarding the appropriate level of funding for health and care in the UK. In this Health Policy paper, we look at the economic impact of the COVID-19 pandemic and historical spending in the UK and comparable countries, assess the role of private spending, and review spending projections to estimate future needs. Public spending on health has increased by 3·7% a year on average since the National Health Service (NHS) was founded in 1948 and, since then, has continued to assume a larger share of both the economy and government expenditure. In the decade before the ongoing pandemic started, the rate of growth of government spending for the health and care sector slowed. We argue that without average growth in public spending on health of at least 4% per year in real terms, there is a real risk of degradation of the NHS, reductions in coverage of benefits, increased inequalities, and increased reliance on private financing. A similar, if not higher, level of growth in public spending on social care is needed to provide high standards of care and decent terms and conditions for social care staff, alongside an immediate uplift in public spending to implement long-overdue reforms recommended by the Dilnot Commission to improve financial protection. COVID-19 has highlighted major issues in the capacity and resilience of the health and care system. We recommend an independent review to examine the precise amount of additional funds that are required to better equip the UK to withstand further acute shocks and major threats to health.

Indexed as

COVID-19Financing, GovernmentHealth ExpendituresHealth PolicyHumansSocial SupportState MedicineUnited Kingdom

Identifiers

PMID33965068
PMCPMC9751707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.